Nutrition and Health Sciences Program, Graduate Division of Biomedical and Biological Sciences, Laney Graduate School, Emory University, 1518 Clifton Road NE, Atlanta, GA 30329, USA.
Nutrition and Health Sciences Program, Graduate Division of Biomedical and Biological Sciences, Laney Graduate School, Emory University, 1518 Clifton Road NE, Atlanta, GA 30329, USA; Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA; Department of Medicine, School of Medicine, Emory University, Atlanta, GA, USA.
J Diabetes Complications. 2014 Jan-Feb;28(1):45-50. doi: 10.1016/j.jdiacomp.2013.10.002. Epub 2013 Oct 11.
We assessed the relative associations of β-cell dysfunction and insulin sensitivity with baseline glycemic status and incident glycemic progression among Asian Indians in the United States.
A 5-sample oral glucose tolerance test was obtained at baseline. Normoglycemia, impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and type 2 diabetes (T2DM) were defined by ADA criteria. The Matsuda Index (ISIM) estimated insulin sensitivity, and the Disposition Index (DIo) estimated β-cell function. Visceral fat was measured by abdominal CT. After 2.5years, participants underwent a 2-sample oral glucose tolerance test. Standardized polytomous logistic regression was used to examine associations with prevalent and incident glycemia.
Mean age was 57±8years and BMI 26.1±4.6kg/m(2). Log ISIM and log DIo were associated with prediabetes and T2DM after adjusting for age, sex, BMI, family history of diabetes, hypertension, and smoking. After adjusting for visceral fat, only DIo remained associated with prediabetes (OR per SD 0.17, 95% CI: 0.70, 0.41) and T2DM (OR 0.003, 95% CI: 0.0001, 0.03). Incidence rates (per 1,000 person-years) were: normoglycemia to IGT: 82.0, 95% CI (40, 150); to IFG: 8.4, 95% CI (0, 41); to T2DM: 8.6, 95% CI (0, 42); IGT to T2DM: 55.0, 95% CI (17, 132); IFG to T2DM: 64.0, 95% CI (3, 316). The interaction between sex and the change in waist circumference (OR 1.8, per SD 95% CI: 1.22, 2.70) and the change in log HOMA-β (OR 0.37, per SD 95% CI: 0.17, 0.81) were associated with glycemic progression.
The association of DIo with baseline glycemia after accounting for visceral fat as well as the association of the change in log HOMA-β with incident glycemic progression implies innate β-cell susceptibility in Asian Indians for glucose intolerance or dysglycemia.
我们评估了β细胞功能障碍和胰岛素敏感性与美国亚裔人群的基线血糖状态和血糖进展事件之间的相对关联。
在基线时进行了 5 样本口服葡萄糖耐量试验。根据 ADA 标准,正常血糖、空腹血糖受损(IFG)、糖耐量受损(IGT)和 2 型糖尿病(T2DM)被定义。Matsuda 指数(ISIM)估计胰岛素敏感性,而处置指数(DIo)估计β细胞功能。通过腹部 CT 测量内脏脂肪。2.5 年后,参与者进行了 2 样本口服葡萄糖耐量试验。使用标准化多项逻辑回归来检查与现患和新发血糖之间的关联。
平均年龄为 57±8 岁,BMI 为 26.1±4.6kg/m2。在调整年龄、性别、BMI、糖尿病家族史、高血压和吸烟后,log ISIM 和 log DIo 与糖尿病前期和 T2DM 相关。在调整内脏脂肪后,只有 DIo 仍然与糖尿病前期(SD 每增加 0.17,95%CI:0.70,0.41)和 T2DM(OR 0.003,95%CI:0.0001,0.03)相关。发病率(每 1000 人年)为:正常血糖到 IGT:82.0,95%CI(40,150);到 IFG:8.4,95%CI(0,41);到 T2DM:8.6,95%CI(0,42);IGT 到 T2DM:55.0,95%CI(17,132);IFG 到 T2DM:64.0,95%CI(3,316)。性别与腰围变化(OR 1.8,SD 95%CI:1.22,2.70)和 logHOMA-β 变化(OR 0.37,SD 95%CI:0.17,0.81)之间的交互作用与血糖进展相关。
在考虑内脏脂肪后,DIo 与基线血糖之间的关联以及 logHOMA-β 变化与新发血糖进展之间的关联表明,亚洲印第安人对葡萄糖耐量或血糖异常存在先天的β细胞易感性。